PortalPublikationenElevation of asymmetric dimethylarginine in patients with un...

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.

Standard

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. / Krempl, Tanja K; Maas, Renke; Sydow, Karsten; Meinertz, Thomas; Böger, Rainer H; Kähler, Jan.

in: EUR HEART J, Jahrgang 26, Nr. 18, 18, 2005, S. 1846-1851.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Krempl, TK, Maas, R, Sydow, K, Meinertz, T, Böger, RH & Kähler, J 2005, 'Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.', EUR HEART J, Jg. 26, Nr. 18, 18, S. 1846-1851. <http://www.ncbi.nlm.nih.gov/pubmed/15860520?dopt=Citation>

APA

Krempl, T. K., Maas, R., Sydow, K., Meinertz, T., Böger, R. H., & Kähler, J. (2005). Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. EUR HEART J, 26(18), 1846-1851. [18]. http://www.ncbi.nlm.nih.gov/pubmed/15860520?dopt=Citation

Vancouver

Krempl TK, Maas R, Sydow K, Meinertz T, Böger RH, Kähler J. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. EUR HEART J. 2005;26(18):1846-1851. 18.

Bibtex

@article{72b2dfd2f021468abf79436b6fa4b44a,
title = "Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.",
abstract = "AIMS: We investigated the role of asymmetric dimethylarginine (ADMA) for clinical outcome of patients with unstable angina. METHODS AND RESULTS: Forty-five patients with stable angina, 36 patients with unstable angina, and 40 healthy controls were included in this study. Coronary artery disease (CAD) patients were prospectively followed for 1 year. ADMA levels were measured at baseline and after 6 weeks using a validated ELISA. Baseline ADMA concentration in controls was significantly lower than in patients with CAD (0.59+/-0.23 vs. 0.76+/-0.17 micromol/L; P",
author = "Krempl, {Tanja K} and Renke Maas and Karsten Sydow and Thomas Meinertz and B{\"o}ger, {Rainer H} and Jan K{\"a}hler",
year = "2005",
language = "Deutsch",
volume = "26",
pages = "1846--1851",
journal = "EUR HEART J",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "18",

}

RIS

TY - JOUR

T1 - Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.

AU - Krempl, Tanja K

AU - Maas, Renke

AU - Sydow, Karsten

AU - Meinertz, Thomas

AU - Böger, Rainer H

AU - Kähler, Jan

PY - 2005

Y1 - 2005

N2 - AIMS: We investigated the role of asymmetric dimethylarginine (ADMA) for clinical outcome of patients with unstable angina. METHODS AND RESULTS: Forty-five patients with stable angina, 36 patients with unstable angina, and 40 healthy controls were included in this study. Coronary artery disease (CAD) patients were prospectively followed for 1 year. ADMA levels were measured at baseline and after 6 weeks using a validated ELISA. Baseline ADMA concentration in controls was significantly lower than in patients with CAD (0.59+/-0.23 vs. 0.76+/-0.17 micromol/L; P

AB - AIMS: We investigated the role of asymmetric dimethylarginine (ADMA) for clinical outcome of patients with unstable angina. METHODS AND RESULTS: Forty-five patients with stable angina, 36 patients with unstable angina, and 40 healthy controls were included in this study. Coronary artery disease (CAD) patients were prospectively followed for 1 year. ADMA levels were measured at baseline and after 6 weeks using a validated ELISA. Baseline ADMA concentration in controls was significantly lower than in patients with CAD (0.59+/-0.23 vs. 0.76+/-0.17 micromol/L; P

M3 - SCORING: Zeitschriftenaufsatz

VL - 26

SP - 1846

EP - 1851

JO - EUR HEART J

JF - EUR HEART J

SN - 0195-668X

IS - 18

M1 - 18

ER -